Literature DB >> 17362717

A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding.

Ian S Fraser1, Hilary O D Critchley, Malcolm G Munro, Michael Broder.   

Abstract

BACKGROUND: There is considerable worldwide confusion in the use of terminologies and definitions around the symptom of abnormal uterine bleeding, and these are leading increasingly to difficulties in setting up multinational clinical trials and in interpreting the results of studies undertaken in single centers.
OBJECTIVE: To develop an agreement process through an international initiative to recommend clear, simple terminologies and definitions that have the potential for wide acceptance.
DESIGN: After widespread consultation with relevant international and national organizations, journal editors, and individuals, a modified Delphi process was developed to assess current use of terminologies, followed by a structured face-to-face meeting of 35 clinicians (mostly gynecologists) and scientists in Washington, DC. Focused small-group discussions led to plenary assessment of concepts and recommendations by using an electronic keypad voting system.
SETTING: An international group of experts on disorders of menstruation. PATIENT(S): Women with complaint of menstrual symptoms. INTERVENTION(S): An international debate and consultation process. MAIN OUTCOME MEASURE(S): Expert debate and anonymous voting on agreement through use of electronic keypads. RESULT(S): There was almost-universal agreement that poorly defined terms of classical origin that are used in differing ways in the English medical language should be discarded and that these should be replaced by simple, descriptive terms with clear definitions that have the potential to be understood by health professionals and patients alike and that can be translated into most languages. The major recommendations were to replace terms such as menorrhagia, metrorrhagia, hypermenorrhea, and dysfunctional uterine bleeding. Suggestions for potentially suitable replacement terms and definitions are made. CONCLUSION(S): A simple terminology has been recommended for the description and definition of symptoms and signs of abnormal uterine bleeding. This article should be a living document and should be part of an ongoing process with international medical and community debate. Classification of causes, investigations, and cultural and quality-of-life issues should be part of the ongoing process.

Entities:  

Mesh:

Year:  2007        PMID: 17362717     DOI: 10.1016/j.fertnstert.2007.01.023

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  19 in total

Review 1.  A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding.

Authors:  Kristen A Matteson; Husam Abed; Thomas L Wheeler; Vivian W Sung; David D Rahn; Joseph I Schaffer; Ethan M Balk
Journal:  J Minim Invasive Gynecol       Date:  2011-11-11       Impact factor: 4.137

Review 2.  The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.

Authors:  Andrew M Kaunitz; Pirjo Inki
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

Review 3.  Mechanisms of normal and abnormal endometrial bleeding.

Authors:  Charles J Lockwood
Journal:  Menopause       Date:  2011-04       Impact factor: 2.953

4.  Practice patterns and attitudes about treating abnormal uterine bleeding: a national survey of obstetricians and gynecologists.

Authors:  Kristen A Matteson; Britta L Anderson; Stephanie B Pinto; Vrishali Lopes; Jay Schulkin; Melissa A Clark
Journal:  Am J Obstet Gynecol       Date:  2011-05-14       Impact factor: 8.661

5.  Questioning our questions: do frequently asked questions adequately cover the aspects of women's lives most affected by abnormal uterine bleeding? Opinions of women with abnormal uterine bleeding participating in focus group discussions.

Authors:  Kristen A Matteson; Melissa A Clark
Journal:  Women Health       Date:  2010-03

6.  Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.

Authors:  Eliza B Geer; Alejandro Ayala; Vivien Bonert; John D Carmichael; Murray B Gordon; Laurence Katznelson; Ekaterina Manuylova; Ismat Shafiq; Vijaya Surampudi; Ronald S Swerdloff; Michael S Broder; Dasha Cherepanov; Marianne Eagan; Jackie Lee; Qayyim Said; Maureen P Neary; Beverly M K Biller
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

7.  Expression of PGR, HBEGF, ITGAV, ITGB3 and SPP1 genes in eutopic endometrium of infertile women with endometriosis during the implantation window: a pilot study.

Authors:  Michele G Da Broi; Carlos V Rocha; Juliana Meola; Wellington P Martins; Filomena M Carvalho; Rui A Ferriani; Paula A Navarro
Journal:  JBRA Assist Reprod       Date:  2017-09-01

8.  Women presenting to an emergency facility with abnormal uterine bleeding: patient characteristics and prevalence of anemia.

Authors:  Kristen A Matteson; Christina A Raker; Stephanie B Pinto; Dana Marie Scott; Gary N Frishman
Journal:  J Reprod Med       Date:  2012 Jan-Feb       Impact factor: 0.142

Review 9.  Classification of menstrual bleeding disorders.

Authors:  Malcolm G Munro
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

10.  Ovarian function after chemotherapy in young breast cancer survivors.

Authors:  K Morarji; O McArdle; K Hui; G Gingras-Hill; S Ahmed; E M Greenblatt; E Warner; S Sridhar; A M F Ali; A Azad; D C Hodgson
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.